Vantage Health (VNTH) 0.0470 $VNTH
Vantage Health changes corporate name to Vantage mHealthcare Inc
M2 - Mon Jan 12, 3:22AM CST
Vantage mHealthcare Inc (OTC:VNTH), a mobile healthcare technology company on Friday announced that its corporate name has officially changed to Vantage mHealthcare Inc from Vantage Health.
Vantage Health Announces Corporate Name Change to Vantage mHealthcare, Inc.
Business Wire - Fri Jan 09, 2:30PM CST
Vantage mHealthcare, Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company"
today announced that the corporate name has officially changed to Vantage mHealthcare, Inc. to better align the strategic direction of the Company within the growing and innovative mobile healthcare technology sector.
Vantage Health Announces Recent Scientific Updates and Corporate Developments
Business Wire - Thu Nov 20, 7:02AM CST
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company" today announces recent scientific updates and corporate developments.
Vantage Health enters into strategic partnership with Theranostics Laboratory
M2 - Thu Oct 30, 8:07AM CDT
Vantage Health Inc (OTC:VNTH), a mobile health technology company, announced on Wednesday the entering into a strategic partnership with Theranostics Laboratory, a translational research company.
Vantage Health Forms Strategic Partnership with Theranostics Laboratory
Business Wire - Wed Oct 29, 7:30AM CDT
Vantage Health Inc., (OTCQB:VNTH) ("Vantage Health" or (the "Company" today announced that it has entered into a strategic partnership with Theranostics Laboratory, a translational research company, with offices in the USA and New Zealand. Theranostics laboratory was founded at the Cleveland Clinic in 2010 and works on subcontracted research, in collaboration with the Auckland Bioengineering Institute (ABI), in New Zealand, and with NASA (via NASA Grant NCC 9-58).
Vantage Health names Edward Rollins to board
M2 - Tue Sep 30, 4:50AM CDT
Vantage Health Inc (OTC: VNTH), a mobile health technology company, announced on Monday that it has appointed Edward Rollins to its board of directors.
Vantage Health Announces Appointment of Edward Rollins, Former Advisor to Four U.S. Presidents, to Its Board of Directors
Business Wire - Mon Sep 29, 7:30AM CDT
Vantage Health Inc., (OTCQB: VNTH) ("Vantage Health" or the "Company" today announced the appointment of Edward Rollins to its Board of Directors.
Vantage Health names Joseph C. Peters to board
M2 - Thu Sep 25, 4:37AM CDT
Vantage Health Inc (OTC:VNTH), a mobile health technology company, announced on Wednesday that it has appointed Joseph C. Peters to its board of directors, effective immediately.
Vantage Health Announces Appointment of Joseph C. Peters, Former White House Drug Policy Office's Acting Deputy Director for State and Local Affairs under Presidents Clinton and Bush, to Its Board of Directors
Business Wire - Wed Sep 24, 7:30AM CDT
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company" today announced the appointment of Joseph C. Peters to its Board of Directors, effective immediately. Mr. Peters will also serve as President of the company. Among other things, he will be involved in exploring possible applications of the Company's technology to narcotics detection. Mr. Peters will replace departing board member Will Rees.
Vantage Health appoints Dr Steven R. Steinhubl as board chairman
M2 - Wed Sep 24, 6:07AM CDT
Vantage Health Inc (OTC: VNTH), a mobile health technology company, on Tuesday announced that it has appointed Steven R. Steinhubl, MD, as chairman of the board. Dr Steinhubl replaces interim chairman Dr Kevin Buckman, who will remain with the company in an advisory capacity.
Vantage Health Names Dr. Steven R. Steinhubl, Director of Digital Medicine at Scripps Translational Science Institute, New Chairman of the Board
Business Wire - Tue Sep 23, 9:21AM CDT
Vantage Health Inc., (OTCQB:VNTH) ("Vantage Health" or (the "Company" today announced the appointment of Steven R. Steinhubl, M.D. as chairman of the board. Dr. Steinhubl replaces interim chairman, Dr. Kevin Buckman who will remain with the company in an advisory capacity.
Tony van Bijleveld, General Manager for Patheon/DPX, and Former General Manager Europe for Alliance Boots Walgreens, Appointed to the Vantage Health Board of Directors
Business Wire - Mon Sep 22, 11:20AM CDT
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company" today announced the appointment of Tony van Bijleveld as an independent member of the Board of Directors of Vantage Health, Inc.
Dr Kevin Buckman Named Chairman and CEO of Vantage Health
Business Wire - Tue Jul 29, 2:51PM CDT
Vantage Health (the "Company" (OTCQB:VNTH) today announced the appointment of Kevin Buckman MD FAAIM, DAAUCM, MACOEM, MRO as Chairman and CEO of the Company.
Vantage Health changes corporate name to Vantage mHealthcare Inc
M2 - Mon Jan 12, 3:22AM CST
Vantage mHealthcare Inc (OTC:VNTH), a mobile healthcare technology company on Friday announced that its corporate name has officially changed to Vantage mHealthcare Inc from Vantage Health.
Vantage Health Announces Corporate Name Change to Vantage mHealthcare, Inc.
Business Wire - Fri Jan 09, 2:30PM CST
Vantage mHealthcare, Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company"
today announced that the corporate name has officially changed to Vantage mHealthcare, Inc. to better align the strategic direction of the Company within the growing and innovative mobile healthcare technology sector. Vantage Health Announces Recent Scientific Updates and Corporate Developments
Business Wire - Thu Nov 20, 7:02AM CST
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company"
today announces recent scientific updates and corporate developments. Vantage Health enters into strategic partnership with Theranostics Laboratory
M2 - Thu Oct 30, 8:07AM CDT
Vantage Health Inc (OTC:VNTH), a mobile health technology company, announced on Wednesday the entering into a strategic partnership with Theranostics Laboratory, a translational research company.
Vantage Health Forms Strategic Partnership with Theranostics Laboratory
Business Wire - Wed Oct 29, 7:30AM CDT
Vantage Health Inc., (OTCQB:VNTH) ("Vantage Health"
or (the "Company" today announced that it has entered into a strategic partnership with Theranostics Laboratory, a translational research company, with offices in the USA and New Zealand. Theranostics laboratory was founded at the Cleveland Clinic in 2010 and works on subcontracted research, in collaboration with the Auckland Bioengineering Institute (ABI), in New Zealand, and with NASA (via NASA Grant NCC 9-58). Vantage Health names Edward Rollins to board
M2 - Tue Sep 30, 4:50AM CDT
Vantage Health Inc (OTC: VNTH), a mobile health technology company, announced on Monday that it has appointed Edward Rollins to its board of directors.
Vantage Health Announces Appointment of Edward Rollins, Former Advisor to Four U.S. Presidents, to Its Board of Directors
Business Wire - Mon Sep 29, 7:30AM CDT
Vantage Health Inc., (OTCQB: VNTH) ("Vantage Health" or the "Company"
today announced the appointment of Edward Rollins to its Board of Directors. Vantage Health names Joseph C. Peters to board
M2 - Thu Sep 25, 4:37AM CDT
Vantage Health Inc (OTC:VNTH), a mobile health technology company, announced on Wednesday that it has appointed Joseph C. Peters to its board of directors, effective immediately.
Vantage Health Announces Appointment of Joseph C. Peters, Former White House Drug Policy Office's Acting Deputy Director for State and Local Affairs under Presidents Clinton and Bush, to Its Board of Directors
Business Wire - Wed Sep 24, 7:30AM CDT
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company"
today announced the appointment of Joseph C. Peters to its Board of Directors, effective immediately. Mr. Peters will also serve as President of the company. Among other things, he will be involved in exploring possible applications of the Company's technology to narcotics detection. Mr. Peters will replace departing board member Will Rees. Vantage Health appoints Dr Steven R. Steinhubl as board chairman
M2 - Wed Sep 24, 6:07AM CDT
Vantage Health Inc (OTC: VNTH), a mobile health technology company, on Tuesday announced that it has appointed Steven R. Steinhubl, MD, as chairman of the board. Dr Steinhubl replaces interim chairman Dr Kevin Buckman, who will remain with the company in an advisory capacity.
Vantage Health Names Dr. Steven R. Steinhubl, Director of Digital Medicine at Scripps Translational Science Institute, New Chairman of the Board
Business Wire - Tue Sep 23, 9:21AM CDT
Vantage Health Inc., (OTCQB:VNTH) ("Vantage Health"
or (the "Company" today announced the appointment of Steven R. Steinhubl, M.D. as chairman of the board. Dr. Steinhubl replaces interim chairman, Dr. Kevin Buckman who will remain with the company in an advisory capacity. Tony van Bijleveld, General Manager for Patheon/DPX, and Former General Manager Europe for Alliance Boots Walgreens, Appointed to the Vantage Health Board of Directors
Business Wire - Mon Sep 22, 11:20AM CDT
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company"
today announced the appointment of Tony van Bijleveld as an independent member of the Board of Directors of Vantage Health, Inc. Dr Kevin Buckman Named Chairman and CEO of Vantage Health
Business Wire - Tue Jul 29, 2:51PM CDT
Vantage Health (the "Company"
(OTCQB:VNTH) today announced the appointment of Kevin Buckman MD FAAIM, DAAUCM, MACOEM, MRO as Chairman and CEO of the Company. 
